| 000 | 01025na a2200313 4500 | ||
|---|---|---|---|
| 999 |
_c8107 _d8107 |
||
| 003 | PC8107 | ||
| 005 | 20180417112633.0 | ||
| 008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_aMorales Cerdán, José María _9576 _eNefrología |
||
| 245 | 0 | 0 |
_aOnce-Monthly Pegylated Epoetin Beta Versus Darbepoetin Alfa Every Two Weeks in Renal Transplant Recipients: A Randomized Trial. _h[artículo] |
| 260 |
_bTransplantation, _c2013 |
||
| 300 | _a95(2):e6-e10. | ||
| 500 | _aFormato Vancouver: Campistol JM, Carreño A, Morales JM, Pallardó L, Franco A, Navarro D et al. TIVOLI Study Group. Once-monthly pegylated epoetin Beta versus darbepoetin alfa every two weeks in renal transplant recipients: a randomized trial. Transplantation. 2013 Jan 27;95(2):e6-e10. | ||
| 501 | _aPMID: 23325012 | ||
| 504 | _aContiene 15 referencias | ||
| 710 |
_986 _aServicio de Nefrología |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/8/pc8107.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||